Oncology Brothers · Health

Oncology Brothers: Practice-Changing Cancer Discussions

The Oncology Brothers Podcast, led by Drs. Rahul and Rohit Gosain, is dedicated to bridging the gap between academic cancer centers and community oncology in the ever-evolving field of hematology & oncology. With a mission to disseminate crucial information to the medical community, this oncology podcast is not for medical advice but rather serves as a beacon for physicians, nurses, trainees, and advanced practice providers (APPs) involved in the care of cancer patients. Drs. Rahul and Rohit Gosain, both esteemed oncologists, bring a wealth of experience and expertise from their general community practice to these discussions. Through short and engaging interviews with world-renowned researchers, clinicians, hematologists, and oncologists, they present practice-changing data in a concise, bite-sized format. Get the latest FDA approvals news, oncology conference highlights, and treatment algorithms in 25 minutes or less. Conversations center around common cancers you see in your clinic like breast cancer, prostate cancer, kidney cancer, bladder cancer, lung cancer, and GI cancers. With new indications and approvals, we talk about how to incorporate this data in your day to day clinical practice. Each episode includes visual presentations so you can follow along within the podcast players and on YouTube @oncbrothers. These visual tools and algorithms will provide an outline on what is covered in each episode. Immediately apply the latest insights and advancements in your daily practice, ensuring the delivery of optimal cancer care to patients within your local communities. If you want to navigate the complexities of your hematology & oncology practice and stay current, the Oncology Brothers Podcast offers invaluable insights and practical takeaways to enhance your professional journey and improve patient outcomes. For more information, please visit: www.oncbrothers.com, and connect with us on Twitter/X/Instagram/TikTok: @oncbrothers, or email us at [email protected] Privacy Policy: https://oncbrothers.com/privacy-policy Terms & Conditions: https://oncbrothers.com/terms-and-conditions

Episodes

Managing Toxicities of Androgen Receptor Pathway Inhibitor (ARPI) in Prostate Cancer

17 Aug 2026

24m

Challenging Cases in Myelodysplastic Syndrome (MDS) - Dr. Amer Zeidan

13 Aug 2026

25m

Treatment Algorithm of Myelodysplastic Syndrome (MDS) in 2026 - Dr. Thomas LeBlanc

10 Aug 2026

27m

Pancreatic Cancer Management - Partners in Practice with Dr. Tim Brown & Ms. Heather Kline

06 Aug 2026

19m

AI processed

Metastatic pancreatic cancer management relies on a multidisciplinary approach, balancing aggressive systemic therapies with patient quality of life. Frontline treatment options include FOLFIRINOX, nalirifox, and gemcitabine/nab-paclitaxel, with selection dictated by patient performance status and comorbidities. Germli...

Treatment Algorithm of Late Relapsed/Refractory Multiple Myeloma (RRMM)

03 Aug 2026

24m

Treatment Algorithm of Early Relapsed/Refractory Multiple Myeloma (RRMM)

30 Jul 2026

22m

ENDURANCE Trial - Time-limited Lenalidomide Maintenance for Standard Risk Myeloma

28 Jul 2026

16m

Managing Toxicities of CAR-T in Multiple Myeloma (MM) – Drs. Caitlin Costello & Joshua Richter

23 Jul 2026

22m

Challenging Cases in Relapsed/Refractory Multiple Myeloma - Drs. Marco Davila & Krina Patel

20 Jul 2026

23m

Treatment Algorithm of Smoldering Myeloma & Newly Diagnosed Multiple Myeloma (NDMM)

16 Jul 2026

22m

EHA2026 Leukemia Highlights: OPTI-AML, KOMET-007, SENTRY

13 Jul 2026

15m

Challenging Cases in Diffuse Large B-cell Lymphoma (DLBCL) – Drs. Gilles Salles & Matt Lunning

09 Jul 2026

23m

EHA2026 Lymphoma Highlights: frontMIND, POLAR-BEAR, HD-MTX for CNS Lymphoma, EPCORE FL-1

06 Jul 2026

18m

AI processed

Key lymphoma research from the 2026 European Hematology Association (EHA) conference reveals significant shifts in clinical practice. The FrontMIND study demonstrates that adding tafasitamab and lenalidomide to R-CHOP improves progression-free survival in high-risk diffuse large B-cell lymphoma (DLBCL), despite increas...

Sacituzumab +/- Pembrolizumab FDA Approval in Triple Negative Breast Cancer: ASCENT-03 / ASCENT-04

04 Jul 2026

20m

ASCO 2026 Breast Highlights: OPTIMA, lidERA, VIKTORIA-1, KEYNOTE-522, ASCENT-03/04, TROPION-Breast02

02 Jul 2026

31m

EHA2026 Multiple Myeloma Highlights: CEPHEUS, MajesTEC-3, MajesTEC-9, MonumenTAL-3, SUCCESSOR-2

29 Jun 2026

24m

Evolving Landscape of Multiple Myeloma: Bispecific Antibodies, CAR-T, CELMoDs

26 Jun 2026

36m

Challenging Cases - Treatment of Relapsed / Refractory Renal Cell Carcinoma (RCC): Dr. Pedro Barata

25 Jun 2026

ASCO 2026 GU Highlights & FDA Approvals with Drs. Brian Rini & Tom Powles (The Uromigos)

22 Jun 2026

33m

To hold or NOT to hold Systemic Therapy with Radiation: Dr. Nina Sanford

18 Jun 2026

23m

Page 2

Follow this podcast in Podwise

Open in Podwise